[99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expressionMuhummad Sohaib Nazir, Vicky Goh, Emma McLean et al.|EJNMMI Research|2023Cited by 9
Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancerD.J. Hughes, Gary Cook, Gitasha Chand et al.|EJNMMI Research|2023Cited by 7
PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancerD.J. Hughes, Gary Cook, Gitasha Chand et al.|British Journal of Cancer|2025Cited by 4
Cerenkov luminescence imaging and flexible autoradiography for specimen margin assessment during breast-conserving cancer surgeryAaditya Sinha, Arnie Purushotham, Zhane Peterson et al.|Radiology Advances|2024Cited by 3
Cerenkov Luminescence Imaging and flexible autoradiography – A first-in-human novel imaging study for intra-operative margin assessment in women undergoing breast-conserving surgery for cancerAaditya Sinha, Arnie Purushotham, Hannah Jeffery et al.|European Journal of Surgical Oncology|2024Cited by 0